Blood News and Research

RSS

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Unlike traditional vaccines, cancer vaccines are not meant to be given to healthy people to prevent cancer. Rather, they are meant to be used in sick patients to strengthen their immune system to better fight the cancer.

4 Oct 2004

Patent pending discovery could help type 2 diabetics

Scientists from MitoChroma Research have recently announced a patent-pending discovery that could complement current medical management modalities for Type 2 Diabetes, insulin resistance and the set of related conditions called "Metabolic Syndrome."

4 Oct 2004

FDA fast tracks Genaera's drug for the treatment of wet age-related macular degeneration

Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).

4 Oct 2004

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

The National Institutes of Health (NIH) announced today that it plans to award about $75 million over five years to five clinical centers and a data coordinating center to conduct studies of islet transplantation in patients with type 1 diabetes.

4 Oct 2004

New technique offers efficient blood cleansing

Blood poisoning is fatal in almost half of all cases. Patients could be helped by efficient blood cleansing. Scientists are working on a new technique that will quickly and effectively retrieve toxic substances from the vital fluid without altering the blood count.

4 Oct 2004

Sibling history is a better predictor of coronary heart disease than parental history or traditional risk factor scoring

Researchers at Johns Hopkins have found that sibling history -- whether or not a brother or sister had early heart disease -- is a better predictor of a person's likelihood of developing coronary heart disease than parental history or traditional risk factor scoring.

4 Oct 2004

3 year study to validate bladder cancer test

A three-year study to validate a test to detect the recurrence of bladder cancer has been initiated by the National Cancer Institute (NCI), at 12 centers across the United States and Canada.

4 Oct 2004

Most malaria deaths among U.S. travelers between 1963 and 2001 were preventable

A new study finds that most malaria deaths among U.S. travelers between 1963 and 2001 were preventable. The study is published in the Oct. 5, 2004, issue of Annals of Internal Medicine, a peer-reviewed medical journal published in Philadelphia by the American College of Physicians.

4 Oct 2004

College students may be ignoring the threat of heart disease

In a groundbreaking study, a former Arizona State University student found college students may be ignoring the threat of heart disease and putting themselves at risk.

4 Oct 2004

Reducing eosinophilic airway inflammation in severe asthma

Eosinophils are a type of white blood cell that constitute from 1 to 3 percent of the total white cell count. When foreign substances or infectious cells enter the body, lymphocytes and neutrophils attract eosinophils which release toxic substances that can destroy abnormal cells. Eosinophils function in allergic responses and in helping resist some infections.

4 Oct 2004

Chiron grants a non-exclusive license to the German Red Cross

Chiron Corporation has announced that it has granted a non-exclusive license to the Blood Transfusion Centers of the German Red Cross (Blutspendediensten des Deutsche Rotes Kreuz, or DRK) for use of the company's HIV-1 and hepatitis C virus (HCV) technology for use in molecular probe "home brew" blood screening.

4 Oct 2004

Artificial neural networks and DNA microarrays to successfully predict clinical outcomes of neuroblastoma patients

Researchers at the National Cancer Institute (NCI), have used artificial neural networks (ANNs) and DNA microarrays to successfully predict the clinical outcome of patients diagnosed with neuroblastoma (NB).

4 Oct 2004

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.

4 Oct 2004

Stress hormones lower threshold for aggression and aggression raises stress hormones

Scientists may be learning why it’s so hard to stop the cycle of violence. The answer may lie in the nervous system.

4 Oct 2004

A revolutionary approach to angiogenesis could make cancer treatment more effective at killing tumours

Dr. Olivier Feron and his team from the University of Louvain Medical School in Brussels have turned the whole concept of targeting tumour blood vessels on its head. Instead of the conventional approach of trying to starve tumour cells of the blood supply they need to grow, they are doing the opposite – opening up the tumour blood supply to allow better access for cancer drugs and more effective radiotherapy.

30 Sep 2004

Antiretroviral treatment may provide protection against HIV transmission during breast-feeding

Women who take combination AIDS drugs not only have benefits for their own health but also may pass along high levels of the medication through breast-feeding, potentially protecting their infants from HIV infection

30 Sep 2004

Male smokers needed for study to investigate new method of improving selenium intake

Around 200 men – including men who smoke – are being sought by researchers in Adelaide, South Australia to take part in a new study aimed at preventing cancer and other health problems.

30 Sep 2004

FDA to highlight benefits and risks of hormone therapy for menopausal symptoms

The Food and Drug Administration (FDA) is implementing a nationwide information campaign to raise awareness about the resources available to address questions related to the benefits and risks of hormone therapy for menopausal symptoms.

29 Sep 2004

Unrecognized iron deficiency can impair immunity in older women

Iron deficiency, which can masquerade as routine, old-age symptoms, was found to impair measures of immunity from 28 percent to 50 percent in a group of seemingly healthy, well-nourished, homebound, older women, age 60 and above, in a Penn State study.

29 Sep 2004

High blood pressure can effect many life activities, including sex

Despite its seeming invisibility, high blood pressure is dangerous, even deadly. Its effects can linger throughout many life activities, including sex.

29 Sep 2004

Blood News and Research

Researchers are studying a vaccine that, in the future, could be the first to treat advanced malignant melanoma

Patent pending discovery could help type 2 diabetics

FDA fast tracks Genaera's drug for the treatment of wet age-related macular degeneration

$75 million over 5 years to study islet transplantation in patients with type 1 diabetes

New technique offers efficient blood cleansing

Sibling history is a better predictor of coronary heart disease than parental history or traditional risk factor scoring

3 year study to validate bladder cancer test

Most malaria deaths among U.S. travelers between 1963 and 2001 were preventable

College students may be ignoring the threat of heart disease

Reducing eosinophilic airway inflammation in severe asthma

Chiron grants a non-exclusive license to the German Red Cross

Artificial neural networks and DNA microarrays to successfully predict clinical outcomes of neuroblastoma patients

Approval of Abilify (aripiprazole) for the treatment of acute bipolar mania

Stress hormones lower threshold for aggression and aggression raises stress hormones

A revolutionary approach to angiogenesis could make cancer treatment more effective at killing tumours

Antiretroviral treatment may provide protection against HIV transmission during breast-feeding

Male smokers needed for study to investigate new method of improving selenium intake

FDA to highlight benefits and risks of hormone therapy for menopausal symptoms

Unrecognized iron deficiency can impair immunity in older women

High blood pressure can effect many life activities, including sex

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News